HbA1c Improvement: 10.3% to 6.1%

Dated: 12 June 2026

Managing Type 2 Diabetes is often described as a marathon, not a sprint. For Anand (name changed for privacy), a 32-year-old male, this marathon began under particularly challenging circumstances following a battle with COVID-19. His journey, documented through several months of clinical consultations at Sugar20 Clinics under the care of Dr. Seelam Rajitha Reddy, serves as a masterclass in how clinical intervention, medication adherence, and aggressive lifestyle changes can yield life-altering results.

The Wake-Up Call: December 2025

Anand’s story with Sugar20 Clinics began in mid-December 2025. He arrived with a complex medical history: he had been diagnosed with Diabetes Mellitus Type 2 five years prior and was a post-COVID recovery patient. During his COVID treatment, he had been administered steroids, which necessitated temporary insulin use to manage spiking blood sugar levels. However, following that period, he had lacked regular monitoring.

His initial clinical profile was concerning. His HbA1c was 10.3%, a level indicating significantly uncontrolled blood sugar. He was experiencing classic symptoms of hyperglycemia, including polyuria (excessive urination), polydipsia (excessive thirst), dry mouth, and generalized weakness. Furthermore, his physical health was under strain; he had a BMI of 28.40 kg/m², categorizing him as overweight, and his blood pressure was elevated at 136/92 mmHg. He also complained of a persistent itchy rash (eczema) and a history of gastritis.

Dr. Reddy’s initial diagnosis was comprehensive: Type 2 Diabetes, post-COVID recovery status, eczema, and gastritis. The immediate goal was stabilization. He was prescribed a combination of  Glimepiride 0.5mg + Metformin 500mg, Sitagliptin 100mg, and nutritional support. Crucially, the doctor provided the first piece of lifestyle advice that would become the cornerstone of his recovery: "Brisk walk for 45 mins a day" and a mandate to check his sugar levels every third day.

Finding a Rhythm: January 2026

By New Year’s Day 2026, the initial intervention began to show progress. Anand reported that his sugars were under control and the itching from his eczema had started to reduce. His blood pressure had also stabilized to a healthier 115/73 mmHg. Despite these gains, his weight remained steady at 70 kg, and his Fasting Blood Sugar (FBS) was still high at 149 mg/dL.

The medical team continued the regimen of  Glimepiride 0.5mg + Metformin 500mg and Sitagliptin 100mg, while also prescribing Sugar Free supplement to support his dietary needs. Dr. Reddy emphasized the need for continued consistency, advising him to exercise for 30-40 minutes daily.

However, the path to health is rarely linear. By late January, Anand faced a common setback: a slight weight gain of 2 kg, bringing his weight to 72 kg and his BMI up to 29.21 kg/m². While his eczema continued to improve, the weight gain was a signal that his metabolic health required even more rigorous attention. At this stage, his FBS was 118 mg/dL and his Post Prandial Blood Sugar (PPBS) was 132 mg/dL.

The Turning Point: February 2026

February marked a significant shift in Anand’s commitment to his lifestyle. He began going to the gym for 45 minutes regularly and reported that he was sleeping better. This increase in physical intensity, combined with medical adherence, led to a breakthrough. By February 28, his weight had dropped to 68.5 kg, and his HbA1c had plummeted to 7%, a massive improvement from the 10.3% recorded just two months earlier.

Dr. Reddy adjusted his medication to reflect his changing needs, introducing Dapagliflozin and Fenofibrate to manage glucose and lipid levels more effectively. He was also prescribed nutritional supplement and  Montelukast 10mg + Fexofenadine 120mg to address his ongoing eczema and allergy symptoms. The doctor’s advice remained firm: "Check sugars every 3rd day" and continue the momentum.

Reaching the Goal: April 2026

The culmination of Anand’s hard work was evident in his final recorded visits in mid-April 2026. His transformation was nothing short of extraordinary. His weight had dropped to 66 kg, resulting in a total loss of 6 kg from his peak in January. His BMI had improved to 26.78 kg/m².

Most importantly, his HbA1c reached 6.1%, placing him in a range that signifies excellent diabetic control. His Fasting Blood Sugar was recorded at 60 mg/dL, and his blood pressure was a stable 118/65 mmHg. Anand attributed this success to a trifecta of efforts: consistent gym attendance, reduced portion sizes in his diet, and the resolution of his gastritis issues.

By April, his diagnosis included Grade 1 Fatty Liver, which is common in diabetic patients, but the overall trend was overwhelmingly positive. His medication was further refined to include  Sitagliptin (100mg),  Empagliflozin 10 MG, and  Rosuvastatin 20mg for cholesterol management, alongside nutritional support. Dr. Reddy’s final advice to him was to maintain moderate-intensity exercise for 1 hour a day and monitor sugars once a week.

Keys to Anand’s Success

Looking back at Anand's journey from a dangerous 10.3% HbA1c to a healthy 6.1%, several key themes emerge that can help others in similar situations:

1. Clinical Guidance and Diagnostic Testing: Anand didn't just "try to eat better." He followed a rigorous schedule of testing. Dr. Reddy prescribed a wide array of tests over the months, including Lipid Profiles, Fundus examinations (to check eye health), RFT (Renal Function Test), LFT (Liver Function Test), and UACR (Urine Albumin-to-Creatinine Ratio). This data-driven approach allowed for precise medication adjustments.
2. Medication Evolution: His prescriptions were never static. They evolved from an initial focus on stabilization with  Glimepiride 0.5mg + Metformin 500mg to a more sophisticated regimen involving SGLT2 inhibitors, which help the kidneys remove sugar through urine.
3. The Power of Small Habits: The doctor’s advice shifted from 45-minute walks to 30-minute exercises, and finally to one hour of moderate-intensity exercise. This gradual scaling helped Anand stay committed without burning out.
4. Managing Comorbidities: Anand’s journey wasn’t just about blood sugar. By addressing his eczema and gastritis, the clinical team improved his overall quality of life, making it easier for him to focus on his fitness goals.
5. Dietary Discipline: The simple mention of "reduced portion size" in the April clinical notes highlights the most difficult but essential part of diabetes management.

Anand’s journey at Sugar20 Clinics is a powerful reminder that while a diagnosis of Type 2 Diabetes especially one complicated by COVID-19 and steroid use can feel overwhelming, it is not a life sentence of poor health. Through the expert guidance of Dr. Seelam Rajitha Reddy and his own unwavering discipline in the gym and at the dinner table, Anand reclaimed his vitality.

His story proves that with the right medical support and a commitment to lifestyle change, "the numbers" (HbA1c, BMI, and BP) can be moved. Today, Anand stands 6 kg lighter, with a heart and metabolism that are significantly stronger than they were just four months ago. For anyone struggling with their own health journey, Anand’s 6.1% HbA1c is a beacon of hope proof that transformation is possible with the right plan and the will to see it through.